CBX7 suppresses urinary bladder cancer progression via modulating AKR1B10–ERK signaling

Nature·May 25

✦ NabkaNews BriefAuto-summarized from multiple outlets · verify with the source

Research suggests that CBX7 may play a role in suppressing cancer progression, potentially through modulation of various signaling pathways. The specific pathways involved appear to vary by cancer type, with CBX7's interaction with AKR1B10-ERK signaling implicated in urinary bladder cancer, and other pathways mentioned in the context of pancreatic ductal adenocarcinoma and glioblastoma. The exact mechanisms and effects of CBX7 on different cancers are still being explored.

Full coverage

DNMT1-Induced Downregulation of CBX7 Inhibits ERK Phosphorylation and Promotes Pancreatic Ductal Adenocarcinoma Progression

Wiley & Sons·May 19

The pathway network of aldo-keto reductase 1b10: a new perspective on gene-targeted therapy

Nature·Jun 22

Chromobox protein homolog 7 suppresses the stem-like phenotype of glioblastoma cells by regulating the myosin heavy chain 9-NF-κB signaling pathway

Nature·Feb 23

Cbx7 is epigenetically silenced in glioblastoma and inhibits cell migration by targeting YAP/TAZ-dependent transcription

Nature·Jun 13